Literature DB >> 31790129

Role of Opioid-Involved Drug Interactions in Chronic Pain Management.

Kevin T Bain, Calvin H Knowlton.   

Abstract

The use of opioids for chronic pain management is extraordinarily common despite substantial evidence of only modest benefits, when compared with nonopioid analgesics. Opioid use is also associated with serious risks, including overdose and death. A growing body of evidence suggests that opioids are involved in significant drug interactions that often go unrecognized in clinical practice. Understanding opioid-involved drug interactions is of great practical importance for all health care professionals caring for patients with chronic pain. In this article, we describe the mechanisms of opioid-involved drug interactions and their potential consequences, which have major public health implications. Additionally, this article provides practical strategies to aid health care professionals in avoiding and mitigating opioid-involved drug interactions in order to obtain a favorable balance in the risk-benefit ratio associated with opioid use. These strategies include using osteopathic principles for chronic pain management, separating the times of administration of the opioid(s) from the nonopioid(s) involved in the interaction, changing the opioid(s) adversely affected by the interaction, changing the nonopioid(s) causing the interaction, and partnering with pharmacists in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31790129     DOI: 10.7556/jaoa.2019.136

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  3 in total

1.  Opioid Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three-Way Drug Interaction Signals.

Authors:  Emily K Acton; Sean Hennessy; Colleen M Brensinger; Warren B Bilker; Todd A Miano; Sascha Dublin; John R Horn; Sophie Chung; Douglas J Wiebe; Allison W Willis; Charles E Leonard
Journal:  Front Pharmacol       Date:  2022-05-10       Impact factor: 5.988

2.  Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury.

Authors:  Charles E Leonard; Colleen M Brensinger; Thanh Phuong Pham Nguyen; John R Horn; Sophie Chung; Warren B Bilker; Sascha Dublin; Samantha E Soprano; Ghadeer K Dawwas; David W Oslin; Douglas J Wiebe; Sean Hennessy
Journal:  Biomed Pharmacother       Date:  2020-07-30       Impact factor: 6.529

3.  Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6-Mediated Drug-Drug Interactions on Tramadol and O-Desmethyltramadol Exposures via Allosteric and Competitive Inhibition.

Authors:  Tao Long; Rodrigo Cristofoletti; Brian Cicali; Veronique Michaud; Pamela Dow; Jacques Turgeon; Stephan Schmidt
Journal:  J Clin Pharmacol       Date:  2021-09-20       Impact factor: 2.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.